SCHEMBL22857073

SCHEMBL22857073

CCC1(C(=O)Nc2ccccc2)CCN(C(C)C)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
CETP P11597 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
CYP2D6 P10635 1/20 0.44
TRPV4 Q9HBA0 1/20 0.42
PTPN11 Q06124 1/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
DRD2 P14416 1/20 0.41
F2R P25116 1/20 0.41
FAAH O00519 2/20 0.40
RET P07949 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20147938 0.85 ALDH1A1 (0.53) ALDH1A1CETPSMN1; SMN2CYP2D6TRPV4
SCHEMBL20069164 0.85 KDM4E (0.49) ALDH1A1CETPSMN1; SMN2NPC1TP53
SCHEMBL10272322 0.84 CETP (0.54) ALDH1A1CETPSMN1; SMN2CYP2D6NPC1
SCHEMBL1147311 0.80 SMN1; SMN2 (0.52) ALDH1A1SMN1; SMN2CYP2D6TRPV4PTPN11
SCHEMBL20070034 0.77 CYP1A2 (0.49) CETPCYP2D6POLBRAB9AFAAH
SCHEMBL18713110 0.75 MME (0.37) ALDH1A1CETPSMN1; SMN2CYP2D6RET
SCHEMBL22857089 0.74 DRD2 (0.49) ALDH1A1CETPPOLBDRD2FAAH
SCHEMBL20148014 0.73 RET (0.37) CETPSMN1; SMN2CYP2D6POLBRET
SCHEMBL16800289 0.71 ALDH1A1 (0.66) ALDH1A1FAAHMAPT
SCHEMBL11564969 0.71 CYP2D6 (0.49) ALDH1A1CYP2D6TRPV4PTPN11CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11648243-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2023-05-16 US disclosed
US-10881652-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2021-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10881652-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors RET, BRAF, RAF1 ALDH1A1 2547/4885CETP 4877/4885SMN1; SMN2 646/4885
US-11648243-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors RET, BRAF, RAF1 ALDH1A1 2547/4885CETP 4877/4885SMN1; SMN2 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.